Cencora, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.About COR
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.
COR Key Statistics
Stock Snapshot
The current Cencora, Inc.(COR) stock price is $360.70, with a market capitalization of 69.96B. The stock trades at a price-to-earnings (P/E) ratio of 45.26 and offers a dividend yield of 61.1%.
On 2025-11-07, Cencora, Inc.(COR) stock moved within a range of $358.29 to $364.08. With shares now at $360.70, the stock is trading +0.7% above its intraday low and -0.9% below the session's peak.
Trading volume for Cencora, Inc.(COR) stock has reached 1.29M, versus its average volume of 1.67M.
The stock's 52-week range extends from a low of $223.92 to a high of $364.36.
The stock's 52-week range extends from a low of $223.92 to a high of $364.36.
COR News
Cencora, Inc. recently announced its full-year results for the period ended September 30, 2025, reporting US$321.33 billion in sales and net income of US$1.55 b...
Deutsche Bank raised the firm’s price target on Cencora (COR) to $371 from $322 and keeps a Buy rating on the shares. Meet Your ETF AI Analyst Discover how Ti...
Cencora (COR) grew its earnings by an average 48.8% per year over the past five years, but growth slowed to just 2.2% in the latest year as revenue is projected...
Analyst ratings
68%
of 19 ratingsMore COR News
Cencora, Inc. ( (COR) ) has released its Q4 earnings. Here is a breakdown of the information Cencora, Inc. presented to its investors. Meet Your ETF AI Analyst...
Image source: The Motley Fool. Nov. 5, 2025 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Robert P. Mauch Executive Vice President a...
In recent trading, shares of Cencora Inc (Symbol: COR) have crossed above the average analyst 12-month target price of $216.42, changing hands for $218.93/share...
Reports Q4 revenue $83.7B, consensus $83.39B. “Cencora (COR) furthered key initiatives in fiscal 2025 to fortify our leading position in healthcare, most notabl...
Cencora (COR) has seen its stock price move slightly this week, catching the eye of investors who are tracking healthcare sector performance. With a steady clim...
Ever wondered if Cencora is offering fair value or if there's hidden upside waiting to be discovered? You're in the right place for a deep dive into what the nu...
BofA analyst Allen Lutz raised the firm’s price target on Cencora (COR) to $345 from $315 and keeps a Neutral rating on the shares. The firm is increasing its t...